Literature DB >> 25504339

Quantitation with chemical tagging reagents in biomarker studies.

Jules A Westbrook1, Josselin Noirel, Janet E Brown, Phillip C Wright, Caroline A Evans.   

Abstract

Isobaric tags for relative and absolute quantitation (iTRAQ), Tandem Mass Tags (TMT) and related chemical tag reagents provide analytical platforms for quantitative proteomics applied to clinical samples. In this Viewpoint article, applications for discovery and targeted modes are discussed with an emphasis on study design and technical considerations in biomarker analysis. The evolution and promise of emerging, related strategies are also discussed. It should be noted that iTRAQ and TMT users contributed to the key debates in the biomarker field, to define strategies for biomarker discovery for identification of clinical biomarkers, and continue to inform design of verification and validation assays via implementation of non-isobaric variants for targeted analyses.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomarker; Tandem mass tags; iTRAQ; mTRAQ

Mesh:

Substances:

Year:  2015        PMID: 25504339     DOI: 10.1002/prca.201400120

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  9 in total

1.  Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment.

Authors:  Li Yang; Qing-Hua Zou; Yan Zhang; Yin Shi; Chun-Rong Hu; Cai-Xia Hui; Xiao-Fei Liu; Yong-Fei Fang
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

Review 2.  Mass spectrometry-based proteomics techniques and their application in ovarian cancer research.

Authors:  Agata Swiatly; Szymon Plewa; Jan Matysiak; Zenon J Kokot
Journal:  J Ovarian Res       Date:  2018-10-01       Impact factor: 4.234

3.  A quantitative proteomics analysis for small molecule Stemazole's effect on human neural stem cells.

Authors:  Huajun Li; Yubo Zhang; Jing Zhang; Chaoran Zhao; Yizi Zhu; Mei Han
Journal:  Proteome Sci       Date:  2020-12-09       Impact factor: 2.480

Review 4.  Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004-2020 period: a systematic review.

Authors:  Rosana Navajas; Fernando Corrales; Alberto Paradela
Journal:  Clin Proteomics       Date:  2021-01-26       Impact factor: 3.988

Review 5.  Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology.

Authors:  Alison L Baird; Sarah Westwood; Simon Lovestone
Journal:  Front Neurol       Date:  2015-11-16       Impact factor: 4.003

6.  Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease.

Authors:  Scott D Bringans; Jun Ito; Thomas Stoll; Kaye Winfield; Michael Phillips; Kirsten Peters; Wendy A Davis; Timothy M E Davis; Richard J Lipscombe
Journal:  EuPA Open Proteom       Date:  2017-01-05

Review 7.  Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias.

Authors:  Becky C Carlyle; Bianca A Trombetta; Steven E Arnold
Journal:  Proteomes       Date:  2018-08-31

8.  Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.

Authors:  Jinyan Zhang; Rong Liang; Jiazhang Wei; Jiaxiang Ye; Qian He; Jiazhou Ye; Yongqiang Li; Zhihui Liu; Yan Lin
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

9.  Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion.

Authors:  Dan-Dan Liu; Piao Luo; Liwei Gu; Qian Zhang; Peng Gao; Yongping Zhu; Xiao Chen; Qiuyan Guo; Junzhe Zhang; Nan Ma; Jigang Wang
Journal:  J Neuroinflammation       Date:  2021-08-09       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.